Publications by authors named "Gabriel Mannis"

Claim this Profile
O
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
Andrew A Lane, Cristina Papayannidis, Emanuele Angelucci, James McCloskey, Gary J Schiller, Gabriel Mannis

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.
Ahmed Aribi, Gabriel N Mannis, Yazan F Madanat, Brian A Jonas, Neil Dunavin

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML.
Vinod A Pullarkat, Mark Levis, James McCloskey, Gabriel N Mannis, Stephen A Strickland

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
Martha L Arellano, Michael J Thirman, John F DiPersio, Maël Heiblig, Eytan M Stein, Gabriel N Mannis

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The improved prognosis of -internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data.
Matthew Schwede, Gladys Rodriguez, Vanessa E Kennedy, Solomon Henry, Douglas Wood, Gabriel N Mannis

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia.
Gabriel N Mannis, Camille N Abboud, Naval G Daver, Guru Subramanian Guru Murthy, Eunice S Wang

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menin Inhibition With Revumenib for -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, John DiPersio, Martha Arellano, Gabriel N Mannis

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Clinical Outcome of Philadelphia Chromosome-Positive AML in Thrombocytopenia-Absent Radius Syndrome.
Alejandro Villar-Prados, Arman Odabas, Joshua R Menke, Kerry Kingham, Gabriel N Mannis

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
Nivaz Brar, Lauren Lawrence, Eula Fung, James L Zehnder, Peter L Greenberg, Gabriel N Mannis

Am J Clin Pathol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Naveen Pemmaraju, Yazan F Madanat, David Rizzieri, Salman Fazal, Raajit Rampal, Gabriel Mannis

Leuk Lymphoma· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123.
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, Brent Tan, Naveen Pemmaraju, Gabriel N Mannis

Leuk Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Amandeep Salhotra, Gabriel Mannis

Leuk Lymphoma· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
Li-Wen Huang, Ying Shi, Charalambos Andreadis, Aaron C Logan, Gabriel N Mannis

J Geriatr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Gabriel Mannis

J Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.
Rory M Shallis, Naval Daver, Jessica K Altman, Rami S Komrokji, Daniel A Pollyea, Gabriel N Mannis

Lancet Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.
Vishesh Khanna, Tali Azenkot, Selina Qiuying Liu, Jason Gilbert, Edna Cheung, Gabriel N Mannis

Leuk Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
Mazie Tsang, Kara Bischoff, Kelly L Schoenbeck, Kim Berry, David O'Riordan, Gabriel N Mannis

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Goldilocks Dilemma in AML: Too Young and Fit, but Not Young and Fit Enough.
Emma C St Martin, Tian Yi Zhang, Gabriel N Mannis

Clin Lymphoma Myeloma Leuk· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
Catherine Lai, Rahul S Bhansali, Eric J Kuo, Gabriel Mannis, Richard J Lin

Am Soc Clin Oncol Educ Book· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi, Gabriel Mannis

J Natl Compr Canc Netw· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukostasis-induced digital ischemia.
Alec Hasty, Mugdha Joshi, Dasom Lee, Gabriel N Mannis

EJHaem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Gabriel Mannis

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Li-Wen Huang, Ying Sheng, Charalambos Andreadis, Aaron C Logan, Gabriel N Mannis

Transplant Cell Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
Vanessa E Kennedy, Gavin Hui, Tali Azenkot, Daria Gaut, Matthew J Wieduwilt, Gabriel N Mannis

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
Sandy On, Carolyn G Rath, Michelle Lan, Bobby Wu, Kimberly M Lau, Gabriel Mannis

Br J Haematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis